PARVOVIRUS B19 AS A CAUSE OF CARDITIS IN COMBINATION WITH MYOZITIS
https://doi.org/10.21518/2079-701X-2018-2-190-193
Abstract
In the article the case of parvovirus B19 infection in a child, which occurred in the form of carditis and myositis, was presented for the first time. There was the rapid progression of the symptoms of acute rhabdomyolysis with a sharp increase in blood levels of creatine phosphokinase, lactate dehydrogenase, myoglobin, ferritin and troponin 1. Ultrasound examination revealed diffuse inflammatory changes in the muscles of the upper and lower extremities with multiple foci of disorganization of the muscular tissue. A high level of PVB19 DNA was determined by the quantitative PCR method, which allowed verifying the parvoviral B19 infection. Rapid clinical and laboratory response in the observed patient was the result of adequate complex therapy, including due to the early use of drugs with antiviral and immunomodulating action.
About the Authors
Т. M. ChernovaRussian Federation
PhD in medicine
M. F. Dubko
Russian Federation
PhD in medicine
References
1. Weigel-Kelley KA, Yoder MC, Srivastava A. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cell. J. Virol 2001, 75: 4110-4116.
2. Brown KE, Hibbs JR, Gallinella G, Anderson SM, Lehman ED, McCarthy P, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994; 330:1192–6.poietic cells. J. Virol., 2001, 75: 4110-6.
3. Lunardi C, Tinazzi E, Bason C et al. Human parvovirus B19 infection and autoimmunity. Autoimmun Rev, 200, 8(2): 116-20.
4. Lefrère JJ, Servant-Delmas A, Candotti D et al. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood, 2005, 106: 2890-2895.
5. Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern. Med., 2006, 260: 285-304.
6. Парвовирусные инфекции: клиническая картина, общие сведения. http://humbio.ru/humbio/vir4pdd/000a11f7.htm.
7. Parvovirus B19 Infection http://emedicine.medscape.com/article/961063-overview#a6.
8. Lunardi C, Tiso M, Borgato L et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur. J. Immunol., 1998, 28: 936-48.
9. Инфекционная эритема (пятая болезнь). http://humbio.ru/humbio/infect_har/001fc3e6.htm.
10. Luo Y, Qiu J. Human parvovirus B19: a mechanistic overview of infection and DNA replication. Future Virol, 2015, 10(2): 155-167.
11. Molina KM, Garcia X, Denfield SW et al. Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatric Cardiology, 34(2): 390-397.
12. Munro K, Croxson MC, Thomas S et al. Three cases of myocarditis in childhood associated with human parvovirus (B19 virus). Pediatric cardiology, 2013, 24(5): 473-475.
13. B19 Infection Clinical Presentation. http://emedicine.medscape.com/article/961063-clinical
14. Scanff JL, Vighetto A, Mekki Y et al. Acute ophthalmoparesis associated with human parvovirus B19 infection. Eur. J. Ophthalmol., 2010, 20(4): 802-804.
15. Oliver ND, Millar A, Pendleton A. A Case Report on Parvovirus B19 associated myositis. Case reports in Rheumatology. 2012, article ID 250537, 2 pages.
16. Kishore J, Singh J. Detection of parvovirus B19 in a case of erythema infectiosum with myositis. Indian Pediatrics, 2006, 43: 814-817.
17. Koliou M, Karaoli E, Soteriades ES et al. Acute hepatitis and myositis associated with erythema infectiosum by parvovirus B19 in an adolescent. BMC Pediatr, 2014, 14: 6.
18. Ishikawa A, Yoto Y, Ohya K et al. Rhabdomyo lysis associated with human parvovirus B19 infection in a patient with Fukuyama-type congenital muscular dystrophy. J. Child. Neurol., 2014, 29(7): 977-9.
19. Парвовирусные инфекции: патогенез. http://humbio.ru/humbio/infect_har/00300d07.htm#001fc3e6.htm.
Review
For citations:
Chernova ТM, Dubko MF. PARVOVIRUS B19 AS A CAUSE OF CARDITIS IN COMBINATION WITH MYOZITIS. Meditsinskiy sovet = Medical Council. 2018;(2):190-193. (In Russ.) https://doi.org/10.21518/2079-701X-2018-2-190-193